chrisvoncsefalvay/vaers-outcomes huggingface dataset:
None from vaccines except sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Sep2022 as dose 4 (booster), single (Lot number: G49694) for covid-19 immunisation. The patient's relevant medical history included: "Crohn's disease" (unspecified if ongoing); "known allergies: Sulpha" (unspecified if ongoing), notes: Known allergies: Sulpha. The patient's concomitant medications were not reported. Past drug history included: Bnt162b2, start date: 22Jan2021, stop date: 22Jan2021, for COVID-19 Immunization, reaction(s): "Sore arm", notes: DOSE 1, SINGLE, Batch/Lot No: EL9262. Vaccination history included: bnt162b2 (DOSE 3, SINGLE, Batch/Lot No: FJ9943), administration date: 16Apr2022, for COVID-19 Immunization, reaction(s): "Sore arm"; bnt162b2 (DOSE 2, SINGLE, Batch/Lot No: EL9266), administration date: 02Feb2021, for COVID-19 Immunization, reaction(s): "Sore arm". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "None from vaccines except sore arm". Therapeutic measures were not taken as a result of pain in extremity.
she had a syncope, she said my head hurts too much I have nausea and she touched her stomach and fell to the floor she lost consciousness, then she opened her eyes but she was stiff and blue without being able to breathe was when we called the rescue
injection site red mark about 4 inches long and 2 inches wide; it is still hard; Vertigo; A spontaneous report was received from a consumer concerning herself, who is a 63-years-old female patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events below the injection site red mark about 4inches long and 2inches wide, it is still hard, vertigo.  The patient's medical history was vertigo diverticulitis. Concomitant medications reported were guaifenesin, pseudoephedrine hydrochloride for drug use for unknown indication.  On 16 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 038821A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events below the injection site red mark about 4inches long and 2inches wide, it is still hard and vertigo.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events below the injection site red mark about 4inches long and 2inches wide, vertigo was unknown. The outcome of event it is still hard was not resolved at the time of reporting.
flu like symptoms; achy joints; tiredness; did not sleep well; sore arm; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Concomitant products included levetiracetam (Keppra).   On 4th November 2019, the patient received the 1st dose of Shingrix. On 4th November 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, joint pain, tiredness and difficulty sleeping. On 5th November 2019, the patient experienced pain in arm. On an unknown date, the outcome of the influenza-like symptoms, joint pain, tiredness, difficulty sleeping and pain in arm were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, joint pain, tiredness, difficulty sleeping and pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix later that day the the patient experienced flu like symptoms described as achy joints, tiredness and not able to sleep that eveningThe next day, the patient had a sore arm which lasted for 2 days. On an unknown date the patient was recovered from the events. The reporter did not consent to follow-up. This case has been linked with another case US2019209688, reported by same reporter. Note:Discrepancy in onset dates of the achy joints and tiredness.
Sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product  (HUMIRA) solution for injection for Ulcerative colitis.    No Medical History information was reported.   In April 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) In 2021, the patient experienced ILLNESS (Sick). At the time of the report, ILLNESS (Sick) had resolved.            No concomitant and treatment medication was provided. There was no reasonable possibility of event sick with Humira. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
A report was received from a health professional on 11/26/01, concerning a female patient of unknown demography, who experienced dizziness and malaise 30 to 40 minutes after receiving an influenza vaccine on 11/26/01. The patient recovered without any treatment on 11/26/01, 2 to 3 hours after receiving Fluvirin. The patient had never previously received an influenza vaccine. There was insufficient information to determine the reporter's causality assessment.
at 1010 am I began to feel extreme fatigue, headache, pain in all of my joints, severe headache, nausea and dizziness.  I have a golf ball size  swelling in my right arm pit with pain to my red breast. It is now 9pm on 2/4/21 and the swelling has not decreased and the pain is getting worse.  I am able to stand up, but still having severe headache and nausea.  will be making doctor visit to check this swelling in my right arm pit.
No adverse effects were reported.; A patient received an improperly stored ROTATEQ; Information has been received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were not provided.     On 04-NOV-2019 or 05-NOV-2019, exact date of administration date unknown, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # S004253, expiration date 21-OCT-2020, dose and strength were unknown) orally for prophylaxis. It was reported vaccine was exposed to the temperature at lowest below 36 degrees Fahrenheit or 2 degrees Celsius (1.3 degrees Celsius) for 2 hours 18 minutes (incorrect product storage).  There was no previous temperature excursion. The data logger was involved. Upon this report, no adverse effects were reported.
Hardened and swollen 2inches at injection sight lasting more than 3 days + sore to touch
pt recv vax 29OCT97 & symptomatic till 17NOV97-burning, itchy rash lt arm, dorsum wrist, & shoulder, no URI sx or other illness;scattered vesicles lt lat chest wall;T4-6 dermatome distribution w/ 1 lesion;lesions wide, raised erythematous
My husband developed symptoms on Monday, May 24th, we both were with our son on the weekend of the 21st. He tested positive on the 22nd, and also tested positive on Friday, the 27th after having tested negative on the 25th. That night of the 27th, I started with mild symptoms and by the 29th my symptoms were more severe of headache, runny nose, fever, achy, and I tested positive. My doctor started me yesterday on Paxlovid. But overall my symptoms are more like a flu and less of a cold. No cough, just nausea, fatigue, aches, etc.
Patient with neuropathy.  Diffuse neuropathy- she has had this after the second vaccines as well.  severe after shot, resolves after a few monhts
Initial report received from a consumer on 26 November 2013: A female patient, whose age, medical history and concomitant medications were not reported, had received a dose of FLUZONE HD (Lot number unknown, route and site of vaccination were not reported), on 23 October 2013. On 23 October 2013, later night after receiving vaccine the patient woke up with severe pain in arm in which she had been vaccinated and her arm felt dead. The pain lasted few hours and then subsided. On 24 October 2013, pain had resolved and she experienced no other symptoms. Corrective treatment was not reported. At the time of this report the outcome of adverse events were recovered. Documents held by sender: none.
received 2nd vaccine on 4/17.  had household exposure, was able to self isolate but tested + for covid on 4/26.  (not considered fully vaccinated 2 weeks post vaccination)
My symptoms began April 28, 2022, I had a runny, headache, cough. I had been exposed to people at work who had tested positive for COVID-19. My test came positive for COVID-19, I did a round of steroids that seemed to help lessen the symptoms but then I developed chest pains and went to the Emergency Room. There they gave me intravenous steroids that helped get clear my chest and I was able to leave that same night. My cough has finally gone away. I did follow up with a Cardiologist for the chest pain who has me wearing a heart monitor.
15 min post vaccination, patient was pale, diaphoretic, reported vision and auditory changes. Felt he was going to pass out. BP 79/52. Transferred.
No adverse event; Patient received a Bivalent Moderna COVID-19 booster as first primary dose by mistake; This spontaneous case was reported by a patient and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a Bivalent Moderna COVID-19 booster as first primary dose by mistake) and NO ADVERSE EVENT (No adverse event) in a 32-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 25-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a Bivalent Moderna COVID-19 booster as first primary dose by mistake). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a Bivalent Moderna COVID-19 booster as first primary dose by mistake) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant information was reported. It was reported that patient never had any brand of COVID-19 vaccine in the past, prior to the bivalent booster and had first dose Bivalent Moderna COVID-19 vaccine No treatment information was provided.
Patient reports extreme soreness/pain at injection site, unable to lift arm, redness of cheeks. Using ibuprofen and heat at injection site. Advised to seek medical attention if she feels necessary.
Both injections, feeling absolute crap; This case was reported by a other health professional via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feels awful. On an unknown date, the outcome of the feels awful was recovered/resolved.   It was unknown if the reporter considered the feels awful to be related to Shingles vaccine.   Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient got the shingles vaccine. The shingles vaccine injections made the patient feeling absolute crap for a few days. The patient stated that it was much better than getting shingles. For tolerance of second dose, refer case US2021AMR222528.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR222528:Same reporter.
Case previously recorded as MA2009-3975. Initial case report received from a pharmacist via Novartis Pharma on 10 NOV 2009. A 1-year-old patient was vaccinated with 0.5 mL of S-OIV FLUVIRIN (batch no. 102040P1) i.m., on NOV 2009. No adverse events was reported. MedCom reference no.: NA09-007885.
flu; Initial information received on 18-Dec-2021 regarding an unsolicited valid Social Media non-serious case received  from a consumer/non-hcp.  This case involves a of unknown age and gender patient who experienced flu while receiving vaccine INFLUENZA VACCINE.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported in unknown administration site for immunization.  On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported " after quitting vaccines I stopped getting the flu they're supposed to prevent ."  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
Patient states within 1 hour of receiving vaccine, had white halo with redness at shot site. 3 hours later, redness increased. Woke up on 10/27/04, redness had increased in size and had edema of arms and fingers. She couldn't bend her arm and it was hot to touch. Called doctor and took Benadryl. Went to physician's assistant on 10/28/04. Was given antibiotic injection. No relief. On 10/29/04 was given Decadron and antibiotic injection. Improved within 2 hours. Took 2 weeks for all edema to resolve. Has dark mark at injection site.
Pt states that following flu shot, she had flu like symptoms for the following two days (sore arm, achiness, etc).  She states that on 9/27/10 she had a headache.  On 9/28/10 she reported left sided facial swelling and swollen/sore lymph nodes.  She states that she also had significant swelling of her left ear.  She was seen in urgent care on 9/28/10 and was diagnosed with a sensitivity reaction versus an infection.  She was prescribed prednisone 20mg x 5 days, Benadryl, and Vicodin for pain.  On 9/29/10 pt was seen by her oncologist who advised increasing the prednisone to 40mg (pt very reluctant to take more than 20mg/day).  Pt states that by that day, her lips were swollen and she had some SOB requiring a nebulizer treatment.  On 9/30/10 pt was seen by her primary care provider who requested that an internal medicine consult.  Pt has facial redness and a migratory rash on her face and neck.
reddish-itchy rash on arm at injection site; reddish-itchy rash on arm at injection site; reddish-itchy rash on arm at injection site; pain and fever at injection site; pain and fever at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (reddish-itchy rash on arm at injection site), PYREXIA (pain and fever at injection site), VACCINATION SITE PAIN (pain and fever at injection site), VACCINATION SITE ERYTHEMA (reddish-itchy rash on arm at injection site) and VACCINATION SITE RASH (reddish-itchy rash on arm at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (pain and fever at injection site) and VACCINATION SITE PAIN (pain and fever at injection site). On 06-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (reddish-itchy rash on arm at injection site), VACCINATION SITE ERYTHEMA (reddish-itchy rash on arm at injection site) and VACCINATION SITE RASH (reddish-itchy rash on arm at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 01-Apr-2021, PYREXIA (pain and fever at injection site) and VACCINATION SITE PAIN (pain and fever at injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (reddish-itchy rash on arm at injection site), VACCINATION SITE ERYTHEMA (reddish-itchy rash on arm at injection site) and VACCINATION SITE RASH (reddish-itchy rash on arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that rash was very annoying.  The patient has used an ice pack which provided only temporary relief.
PATIENT RECIEVED #6 ANTHRAX VACCINATION ON 17 SEP 2003 AND REPORTED TO CLINIC ON 19 SEP 2003 WITH CELLULITIS AND HYPERSENSITIVITY REACTION ON LEFT ARM UP THROUGH CHEST AND NECK REGION.
arm soreness/ache after receiving the injection; arm soreness/ache after receiving the injection; Patient was worried; This is a spontaneous report from a contactable consumer (patient wife). A 77-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 04Mar2021 (at the age of 77 years old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included ibuprofen (ADVIL [IBUPROFEN]), lisinopril (LISINOPRIL) at a dose of 20 mg, fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) at a dose of 2 puffs of that at bed time, pravastatin (PRAVASTATIN) at a dose of 20 mg at bed time and famotidine (PEPCID AC) at a dose of in the morning, all the drugs taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the patient experienced arm soreness/ache after receiving the injection and patient was worried. Therapeutic measures were taken as a result of events arm soreness/ache after receiving the injection included treatment with Tylenol at once daily and Benadryl at a dose 0f 25 mg. The outcome of the events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : -PFIZER INC-2021245395 Same reporter/drug/AE, different patient
Patient developed hives around the local injection site 3 days after receiving a flu shot. Hive symptoms lasted 5 days.
priot to injection patient was nervous. meds. She went to the bathroom returned still nervous.  She relaxed , agreed to get injection.  She then looked lightheaded but responsive to me.  Appreared fanit.  VS: BP 108/85, P: 85 O2 -98%
Approximately 7 minutes after giving MENVEO patient started to complain of tightness in her throat and mild difficulty swallowing. She was given BENADRYL 50 mg and monitored for another 30 minutes. Patient was feeling better and her symptoms were gone. She was sent home. On June 8th patient woke up at 1235 AM feeling dizzy, weak, and tightness in her throat. She was given a CLARITIN 10 mg and went back to sleep. Patient woke that morning and ate a normal breakfast but continued to have dizziness, weakness, and tightness in throat. It became worse around 130 and she was taken to an Urgent care. Upon arriving patient continued to complain of dizziness, weakness, and difficulty swallowing. An EKG showed that the patient had tachycardia. She was sent to the hospital via EMS for suspected allergic reaction to vaccine. In the ER she had several labs drawn which were all normal. She was given an IV bolus of saline, ANTIVERT, TORADOL, and monitored in the ER. By 1515 she was "feeling better" and released from the ER. She was told to FUP in PCP office.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (very large red going all top of her arm, had like a dark red border), MYALGIA (sore arm), ARTHRALGIA (soreness was much more intense on her shoulder too) and VACCINATION SITE ERYTHEMA (red mark at the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced MYALGIA (sore arm). On 27-Jan-2021, the patient experienced ERYTHEMA (very large red going all top of her arm, had like a dark red border). On an unknown date, the patient experienced ARTHRALGIA (soreness was much more intense on her shoulder too) and VACCINATION SITE ERYTHEMA (red mark at the injection site). On 18-Jan-2021, MYALGIA (sore arm) had resolved. At the time of the report, ERYTHEMA (very large red going all top of her arm, had like a dark red border) had not resolved and ARTHRALGIA (soreness was much more intense on her shoulder too) and VACCINATION SITE ERYTHEMA (red mark at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient reported concomitant medication of an antidepressant, not otherwise specified. Treatment taken by the patient was Ibuprofen for soreness and occasionally pills for allergic reaction.
Headache, Myalgia & arthralgia Narrative: Missed two days of work following second dose due to the above symptoms
Fever , fatigue, body aches, headache, everyday and on 6th of March I had severe amplified hearing were I couldn?t deal with any noise whatsoever. Just little things were so bothersome I couldn?t function all day. The next day it disappeared or I was going to doctor. I wouldn?t have been able to live that way without going crazy. I felt like I needed ear plugs.
This spontaneous report was received from a physician referring to an unspecified number of patients of unknown age and gender. Information regarding medical history or concurrent conditions were not reported. On unknown dates, the patients were vaccinated with 17 improperly stored doses of PROQUAD (which had the lot number reported as M004894, expiration date 26-JUL-2017) (dose, route and anatomical site of vaccination were not informed). Information regarding concomitant medication was not provided. No adverse effects were reported. And there was not product quality complaint involved. This is one of two cases from the same reporter. Additional information has been requested.
Inflammation of neck linphatic nodes and discomfort that lasted for 72 hrs. Recurring body fatigue almost daily for the last 3 weeks after the shot.
I woke up at 3am with body aches and a headache and a 99.9 temperature taken via forehead. By 10am, I had chills and could not get warm. I have taken Advil and Tylenol alternating every 4-6hrs. At 12pm I was feeling very dizzy. I took my temperature and it was 95.6 via forehead. I took it twice and took the children's temps to verify that it was working correctly. I also used an oral thermometer and got 95.7. It is now almost 10pm and I still have a 95.6F temp, chills, body aches, headache and dizziness. At work daily my temperature is consistently 97.5 using a forehead thermometer each morning and after lunch.